(Q24245285)

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Neonatal outcome in a randomized, controlled trial of low-dose aspirin in high-risk pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low-dose aspirin in primigravidae with positive roll-over test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low-dose aspirin in prevention and therapy of hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Follow-up of children in the Italian Study of Aspirin in Pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Administration time-dependent influence of aspirin on blood pressure in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low dose acetyl salicylic acid in severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Prevention of pre-eclampsia and placental insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

The effect of low dose aspirin on bleeding times.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

The effect of acetaminophen on prostacyclin production in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Antiplatelet agents for preventing and treating pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Antiplatelet agents for preventing pre-eclampsia and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Interventions for preventing pre-eclampsia and its consequences: generic protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Energy and protein intake in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

The safe motherhood initiative: a call to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Magnesium supplementation in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Early platelet consumption in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Current topic: pre-eclampsia and the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Maternal mortality--a neglected tragedy. Where is the M in MCH?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Antioxidants for preventing pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Aspirin for preventing and treating pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

MATERNAL VASCULAR PROSTACYCLIN ACTIVITY IN PRE-ECLAMPSIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

The effect of low-dose aspirin on fetal urine output and amniotic fluid volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

The effect of low-dose aspirin on umbilical artery Doppler measurements

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin therapy to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

The use of low-dose aspirin to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin and nulliparae

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin and hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Prevention of pre-eclampsia by early antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin and twin pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Effect on fetal circulation of low-dose aspirin for prevention and treatment of pre-eclampsia and intrauterine growth restriction: Doppler flow study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Prevention of hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Where next for prophylaxis against pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

A randomised trial of low dose aspirin for primiparae in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

A randomised trial of low dose aspirin for primiparae in pregnancy (Golding)/Barbados low dose aspirin study in pregnancy (BLASP) (Rotchell et al.)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Low Dose Aspirin for the Treatment of Fetal Growth Restriction: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Administration time-dependent effects of aspirin in women at differing risk for preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Uterine Doppler in the identification of patients at risk for hypertension and IUGR

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004659.PUB2

7 January 2021

10.1002/14651858.CD004659.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17443552

1 reference

Consolidated OpenCitations Corpus – April 2017